RACGP response to ACCC review of the merger between Australian Clinical Labs Limited and Healius Limited

Date: 29 May 2023

The RACGP has responded to the Australian Competition and Consumer Commission (ACCC) review of the merger between Australian Clinical Labs Limited (ACL) and Healius Limited (Healius). The RACGP letter highlights the potential impacts of this merger on access to healthcare for patients across Australia.

Read the submission

Letter to ACCC re Pathology Merger - 29 May 2023 (PDF)